Amphastar Pharma (AMPH) Reports Q3 Loss of $0.01/Share

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.01), versus ($0.07) reported last year. Revenue for the quarter came in at $63.9 million, versus $59.7 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00